# Effects of Peripherally Acting µ-opioid Receptor Antagonists on Acute Pancreatitis

> **NCT04743570** · PHASE2,PHASE3 · COMPLETED · sponsor: **Asbjørn Mohr Drewes** · enrollment: 105 (actual)

## Conditions studied

- Acute Pancreatitis

## Interventions

- **DRUG:** Placebo treatment
- **DRUG:** Methylnaltrexone treatment

## Key facts

- **NCT ID:** NCT04743570
- **Lead sponsor:** Asbjørn Mohr Drewes
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-14
- **Primary completion:** 2023-04-09
- **Final completion:** 2023-04-20
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2023-04-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04743570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04743570, "Effects of Peripherally Acting µ-opioid Receptor Antagonists on Acute Pancreatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04743570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*